![](/img/cover-not-exists.png)
PMO-235 A randomised placebo-controlled double-blind study of Octasa ® 4.8 g/day (800 mg tablets 5-ASA) for the induction of endoscopic remission in patients with active ulcerative colitis
Feagan, B G, Mittmann, U, Gilgen, D, Wong, C J, Mikhailova, E, Levchenko, O, Marakhouski, YVolume:
61
Language:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2012-302514b.235
Date:
July, 2012
File:
PDF, 61 KB
english, 2012